LANDOS BIOPHARMA INC has a total of 43 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ESTEVE PHARMACEUTICALS SA, SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES and DONG WHA PHARM IND CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 5 | |
#3 | Republic of Korea | 5 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Israel | 4 | |
#6 | Canada | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Hungary | 1 | |
#11 | Japan | 1 | |
#12 | New Zealand | 1 | |
#13 | Serbia | 1 | |
#14 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Hontecillas Raquel | 37 |
#2 | Bassaganya-Riera Josep | 31 |
#3 | Gandour Richard | 22 |
#4 | Carbo Barrios Adria | 21 |
#5 | Cooper Julian D | 18 |
#6 | Leber Andrew | 17 |
#7 | Bassaganya Riera Josep | 5 |
#8 | Josep Bassaganya-Riera | 3 |
#9 | Raquel Hontecillas | 3 |
#10 | Cooper Julian | 2 |
Publication | Filing date | Title |
---|---|---|
US2020010417A1 | NLRX1 ligands | |
US10487057B1 | NLRX1 ligands | |
CN111511904A | Therapies using lanthionine C-like protein 2 ligands and cells prepared therewith | |
KR20200087273A | Lanthionine synthetase c-like 2-based therapeutics |